Correlation of NM23-H1 cytoplasmic expression with metastatic stage in human prostate cancer tissue
β Scribed by Immacolata Andolfo; Daniela De Martino; Lucia Liguori; Giuseppe Petrosino; Giancarlo Troncone; Nicoletta Tata; Alessia Galasso; Cristin Roma; Francesco Chiancone; Stefano Zarrilli; Gianluigi Arrigoni; Stefania Staibano; Ciro Imbimbo; Massimo Zollo
- Publisher
- Springer-Verlag
- Year
- 2011
- Tongue
- English
- Weight
- 469 KB
- Volume
- 384
- Category
- Article
- ISSN
- 0028-1298
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The nm23 gene is a potential metastasis-suppressor gene originally identified in a murine melanoma line. Several investigators have reported the probable inverse association of nm23 expression with disease prognosis and/or metastasis. Since there are now 2 known isotypes of human nm23, namely nm23-H
## Abstract ## Introduction The purpose of this study was to evaluate the value of nm23βH1 and proliferating cell nuclear antigen (PCNA) expression as well as other confirmed prognostic factors in predicting the clinical outcome after definitive surgery of pathologic stage I nonβsmall cell lung ca
The characteristic sclerotic appearance of bone metastases from prostate cancer is unexplained but could involve excess peritumoural activity of osteoblast mitogens such as the insulin-like growth factors (IGFs). Since prostatic metastases are distinguished by androgen-dependent secretion of prostat
## Abstract Recent studies have demonstrated that two SIBLING family members, bone sialoprotein (BSP) and osteopontin (OPN), are overexpressed in human prostate cancer. The expression of these proteins is associated with the acquisition of a metastatic phenotype by cancer cells and a poor prognosis